Showing 1 - 6 results of 6 for search 'Pu‐Yuan Xing', query time: 0.04s Refine Results
  1. 1
    A real‐world study of dacomitinib in later‐line settings for advanced non‐small cell lung cancer patients harboring EGFR mutations

    A real‐world study of dacomitinib in later‐line settings for advanced non‐small cell lung cancer patients harboring EGFR mutations by Hong‐Shuai Li, Jin‐Yao Zhang, Xiang Yan, Hai‐Yan Xu, Xue‐Zhi Hao, Pu‐Yuan Xing, Yan Wang

    Published 2022-02-01
    Get full text
    Article
  2. 2
    Efficacy and safety of concomitant immunotherapy and denosumab in patients with advanced non-small cell lung cancer carrying bone metastases: A retrospective chart review

    Efficacy and safety of concomitant immunotherapy and denosumab in patients with advanced non-small cell lung cancer carrying bone metastases: A retrospective chart review by Hong-Shuai Li, Si-Yu Lei, Jun-Ling Li, Pu-Yuan Xing, Xue-Zhi Hao, Fei Xu, Hai-Yan Xu, Yan Wang

    Published 2022-08-01
    Get full text
    Article
  3. 3
    Influence of PD‐L1 expression on the efficacy of EGFR‐TKIs in EGFR‐mutant non‐small cell lung cancer

    Influence of PD‐L1 expression on the efficacy of EGFR‐TKIs in EGFR‐mutant non‐small cell lung cancer by Si‐Yu Lei, Hai‐Yan Xu, Hong‐Shuai Li, Ya‐Ning Yang, Fei Xu, Jun‐Ling Li, Zhi‐Jie Wang, Pu‐Yuan Xing, Xue‐Zhi Hao, Yan Wang

    Published 2023-08-01
    Get full text
    Article
  4. 4
    Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis

    Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis by Hao‐Hua Zhu, Yu‐Tao Liu, Yu Feng, Li‐Na Zhang, Tong‐Mei Zhang, Gui‐Lan Dong, Pu‐Yuan Xing, Hong‐Yu Wang, Yuan‐Kai Shi, Xing‐Sheng Hu

    Published 2021-10-01
    Get full text
    Article
  5. 5
    Afatinib and Dacomitinib Efficacy, Safety, Progression Patterns, and Resistance Mechanisms in Patients with Non-Small Cell Lung Cancer Carrying Uncommon <i>EGFR</i> Mutations: A Comparative Cohort Study in China (AFANDA Study)

    Afatinib and Dacomitinib Efficacy, Safety, Progression Patterns, and Resistance Mechanisms in Patients with Non-Small Cell Lung Cancer Carrying Uncommon <i>EGFR</i> Mutations: A Co... by Hong-Shuai Li, Shou-Zheng Wang, Hai-Yan Xu, Xiang Yan, Jin-Yao Zhang, Si-Yu Lei, Teng Li, Xue-Zhi Hao, Tao Zhang, Guang-Jian Yang, Li-Qiang Zhou, Peng Liu, Yu-Ying Wang, Xing-Sheng Hu, Pu-Yuan Xing, Yan Wang

    Published 2022-10-01
    Get full text
    Article
  6. 6
    What are the clinical symptoms and physical signs for non‐small cell lung cancer before diagnosis is made? A nation‐wide multicenter 10‐year retrospective study in China

    What are the clinical symptoms and physical signs for non‐small cell lung cancer before diagnosis is made? A nation‐wide multicenter 10‐year retrospective study in China by Pu‐Yuan Xing, Yi‐Xiang Zhu, Le Wang, Zhou‐Guang Hui, Shang‐Mei Liu, Jian‐Song Ren, Ye Zhang, Yan Song, Cheng‐Cheng Liu, Yun‐Chao Huang, Xian‐Zhen Liao, Xiao‐Jing Xing, De‐Bin Wang, Li Yang, Ling‐Bin Du, Yu‐Qin Liu, Yong‐Zhen Zhang, Yun‐Yong Liu, Dong‐Hua Wei, Kai Zhang, Ju‐Fang Shi, You‐Lin Qiao, Wan‐Qing Chen, Jun‐Ling Li, Min Dai, the LuCCRES Group

    Published 2019-07-01
    Get full text
    Article

Search Tools: